
Scilex Holding Company
960 San Antonio Road, Palo Alto, CA, 94303, United States
Overview
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products with more efficient and effective delivery solutions for the treatment of pain.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 1
Sector focus
- Health Care
- Medical
- Pharmaceutical
Investment portfolio
- Datavault AI
Led · Equity · Sep 2025
Datavault AI offers a patented platform that combines artificial intelligence, Web 3.0 architecture and blockchain-secured data trading to give individuals and enterprises tools to understand, price and generate revenue from their data assets. Its system underpins several planned exchanges—including the International Elements Exchange, International NIL Exchange and American Politics Exchange—and is designed to address market needs for trust, data integrity and monetization. The company’s roadmap includes strengthening a high-performance supercomputing infrastructure and broadening its network of independent data exchanges. Datavault AI believes its technology is well positioned to capture growth opportunities in biotechnology, natural resources, energy and entertainment, markets projected to benefit from an AI sector expected to reach $1.8 trillion by 2030. Partnerships with Brookhaven National Laboratory and IBM WatsonX underpin its technical capabilities. While no revenue or user figures were disclosed, management views the new capital as critical to scaling operations and driving future income streams.
Team
Henry Ji
Chief Executive Officer and President
LinkedIn